PDF herunterladen
Pharmacopsychiatry 1988; 21(6): 283-284
DOI: 10.1055/s-2007-1016977
Workshop III

© Georg Thieme Verlag KG Stuttgart · New York

The New Generation of Selective Monoamine Oxidase-lnhibitors: Biochemical, Pharmacological and Clinical Perspectives

P.  Riederer1 , G.  Laux1 , H.  Beckmann1 , B.  Saletu2 , P.  Waldmeier6 , J.  Fritze1 , M.  DaPrada7 , H. J. Möller4 , M.  Schmauss3 , H.  Przuntek5
  • 1Department of Psychiatry, University of Würzburg, FRG
  • 2Department of Psychiatry, University of Vienna, Austria
  • 3Department of Psychiatry, University of Munich, FRG
  • 4Department of Psychiatry, Techn. Univ. of Munich, FRG
  • 5Department of Neurology, University of Bochum, FRG
  • 6Research Department, Ciba-Geigy AG, Basle, Switzerland
  • 7Pharmaceutical Research Department, Hoffmann-La Roche & Co. Ltd. Basle, Switzerland
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
13. März 2008 (online)

Auch verfügbar auf